{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:31:54Z","timestamp":1773775914001,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.01.081","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T11:50:54Z","timestamp":1553082654000},"page":"5754-5761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Accelerating measles and rubella elimination through research and innovation \u2013 Findings from the Measles & Rubella Initiative research prioritization process, 2016"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-5735","authenticated-orcid":false,"given":"Gavin B.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balcha G.","family":"Masresha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-3513","authenticated-orcid":false,"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Shefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-3144","authenticated-orcid":false,"given":"Jennifer L.","family":"Kriss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Durrheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Linkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Goodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jir111","article-title":"A world without measles","volume":"204","author":"Strebel","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0010","article-title":"Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28-30 July 2010","volume":"204","author":"World Health Organization","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.01.081_b0015","first-page":"B5","article-title":"Decade of vaccine collaboration","volume":"31","author":"Global Vaccine Action Plan","year":"2013","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2019.01.081_b0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm6642a6","article-title":"Progress toward regional measles elimination \u2013 Worldwide, 2000\u20132016","volume":"66","author":"Dabbagh","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.01.081_b0025","series-title":"Global measles and rubella strategic plan: 2012","first-page":"42","author":"World Health Organization","year":"2012"},{"issue":"45","key":"10.1016\/j.vaccine.2019.01.081_b0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.15585\/mmwr.mm6645a4","article-title":"Progress in rubella and congenital rubella syndrome control and elimination - Worldwide, 2000\u20132016","volume":"66","author":"Grant","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.01.081_b0035","unstructured":"Global Burden of Disease 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet; 2017."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0040","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.vaccine.2017.10.065","article-title":"Measles and rubella global strategic plan 2012\u20132020 midterm review report: background and summary","volume":"36","author":"Orenstein","year":"2018","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0045","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.vaccine.2017.09.026","article-title":"Measles and rubella global strategic plan 2012\u20132020 midterm review","volume":"36","author":"Orenstein","year":"2018","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.01.081_b0050","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox\u2013an overview of the past, present, and future","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.081_b0055","doi-asserted-by":"crossref","first-page":"e1000405","DOI":"10.1371\/journal.pmed.1000405","article-title":"The role of research in viral disease eradication and elimination programs: lessons for malaria eradication","volume":"8","author":"Breman","year":"2011","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0060","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/infdis\/jiu181","article-title":"Oversight role of the independent monitoring board of the global polio eradication initiative","volume":"210","author":"Rutter","year":"2014","journal-title":"J Infect Dis"},{"issue":"32","key":"10.1016\/j.vaccine.2019.01.081_b0065","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2012.04.058","article-title":"Research priorities for global measles and rubella control and eradication","volume":"30","author":"Goodson","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.081_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.07.039","article-title":"Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005","volume":"25","author":"Muller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.081_b0075","unstructured":"National Center for Immunization and Respiratory Disease CfDCaP. Global measles and rubella research external peer review; 2009."},{"issue":"13","key":"10.1016\/j.vaccine.2019.01.081_b0080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.vaccine.2015.11.038","article-title":"Global vaccine and immunization research forum: opportunities and challenges in vaccine discovery, development, and delivery","volume":"34","author":"Ford","year":"2016","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2019.01.081_b0085","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.vaccine.2019.02.058","article-title":"Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey","volume":"37","author":"Kriss","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.081_b0090","unstructured":"World Health Organization. Global Measles and Rubella Strategic Plan 2012-2020; 2012. http:\/\/www.who.int\/immunization\/newsroom\/Measles_Rubella_StrategicPlan_2012_2020.pdf [accessed March 7, 2013]."},{"key":"10.1016\/j.vaccine.2019.01.081_b0095","doi-asserted-by":"crossref","first-page":"15585","DOI":"10.1038\/ncomms15585","article-title":"The geography of measles vaccination in the African Great Lakes region","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.081_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002255","article-title":"Demographic transition and the dynamics of measles in six provinces in China: a modeling study","volume":"14","author":"Li","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.01.081_b0105","doi-asserted-by":"crossref","unstructured":"Kriss JL, Stanescu A, Pistol A, Butu C, Goodson JL. The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015. Risk analysis : an official publication of the Society for Risk Analysis; 2016.","DOI":"10.1111\/risa.12669"},{"key":"10.1016\/j.vaccine.2019.01.081_b0110","doi-asserted-by":"crossref","unstructured":"Goel K, Naithani S, Bhatt D, Khera A, Sharapov UM, Kriss JL, et al. The World Health Organization Measles Programmatic Risk Assessment Tool-Pilot Testing in India, 2014. Risk analysis: an official publication of the Society for Risk Analysis; 2016.","DOI":"10.1111\/risa.12615"},{"key":"10.1016\/j.vaccine.2019.01.081_b0115","doi-asserted-by":"crossref","unstructured":"Kriss JL, De Wee RJ, Lam E, Kaiser R, Shibeshi ME, Ndevaetela EE, et al. Development of the World Health Organization Measles Programmatic Risk Assessment Tool Using Experience from the 2009 Measles Outbreak in Namibia. Risk analysis: an official publication of the Society for Risk Analysis; 2016.","DOI":"10.1111\/risa.12544"},{"key":"10.1016\/j.vaccine.2019.01.081_b0120","article-title":"Development of a district-level programmatic assessment tool for risk of measles virus transmission","author":"Lam","year":"2015","journal-title":"Risk Anal: an official publication of the Society for Risk Analysis"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2019.01.081_b0125","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1093\/infdis\/jix077","article-title":"Expansion of surveillance for vaccine-preventable diseases: building on the global polio laboratory network and the global measles and rubella laboratory network platforms","volume":"216","author":"Mulders","year":"2017","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2019.01.081_b0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15585\/mmwr.mm6517a3","article-title":"Global measles and rubella laboratory network support for elimination goals, 2010\u20132015","volume":"65","author":"Mulders","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9832","key":"10.1016\/j.vaccine.2019.01.081_b0135","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","article-title":"Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data","volume":"379","author":"Simons","year":"2012","journal-title":"Lancet (London, England)."},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.081_b0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1377\/hlthaff.2015.1086","article-title":"Return on investment from childhood immunization in low- and middle-income countries, 2011\u201320","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.01.081_b0145","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2012.11.035","article-title":"The estimated mortality impact of vaccinations forecast to be administered during 2011\u20132020 in 73 countries supported by the GAVI Alliance","volume":"31","author":"Lee","year":"2013","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2019.01.081_b0150","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1016\/j.vaccine.2014.06.035","article-title":"Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone, Ethiopia","volume":"32","author":"Wallace","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.081_b0155","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2468-2667(17)30026-9","article-title":"The price of delaying measles eradication","volume":"2","author":"Durrheim","year":"2017","journal-title":"Lancet Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.081_b0160","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/risa.12331","article-title":"Systematic review of health economic analyses of measles and rubella immunization interventions","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal: an official publication of the Society for Risk Analysis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.081_b0165","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/risa.12454","article-title":"Synthesis of evidence to characterize national measles and rubella exposure and immunization histories","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal: an official publication of the Society for Risk Analysis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.081_b0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.081_b0175","doi-asserted-by":"crossref","first-page":"34541","DOI":"10.1038\/srep34541","article-title":"Measuring populations to improve vaccination coverage","volume":"5","author":"Bharti","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.081_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/trstmh\/trx018","article-title":"Time for an immunisation paradigm shift","volume":"111","author":"Durrheim","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.01.081_b0185","unstructured":"Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. The Lancet."},{"key":"10.1016\/j.vaccine.2019.01.081_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","article-title":"Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects","volume":"128","author":"Arya","year":"2017","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.vaccine.2019.01.081_b0195","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1016\/j.vaccine.2015.02.074","article-title":"A microneedle patch containing measles vaccine is immunogenic in non-human primates","volume":"33","author":"Edens","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.081_b0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/infdis\/jiy139","article-title":"A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques","volume":"218","author":"Joyce","year":"2018","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2019.01.081_b0205","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1017\/S0950268815000540","article-title":"Investigation of a measles outbreak in Zimbabwe, 2010: potential of a point of care test to replace laboratory confirmation of suspected cases","volume":"143","author":"Shonhai","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.081_b0210","first-page":"55","article-title":"The role of extended and whole genome sequencing for tracking transmission of measles and rubella viruses: report from the Global Measles and Rubella Laboratory Network meeting, 2017","volume":"93","author":"World Health Organiazation","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.081_b0215","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiv272","article-title":"Whole-genome sequencing during measles outbreaks","volume":"212","author":"Rota","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.081_b0220","unstructured":"The role of extended and whole genome sequencing for tracking transmission of measles and rubella viruses: report from the Global Measles and Rubella Laboratory Network meeting, 2017. Releve epidemiologique hebdomadaire\/Section d'hygiene du Secretariat de la Societe des Nations\u202f=\u202fWeekly epidemiological record\/Health Section of the Secretariat of the League of Nations 2018;93(6):55\u20139."},{"key":"10.1016\/j.vaccine.2019.01.081_b0225","unstructured":"World Health Organiazation. Global Routine Immunization Strategies and Practices (GRISP): a companion document to the Global Vaccine Action Plan (GVAP); 2016."},{"issue":"45","key":"10.1016\/j.vaccine.2019.01.081_b0230","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.15585\/mmwr.mm6545a5","article-title":"Global routine vaccination coverage, 2015","volume":"65","author":"Casey","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.01.081_b0235","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","article-title":"Measles","volume":"2","author":"Rota","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2019.01.081_b0240","unstructured":"World Health Organization. Planning and implementing high-quality supplementary immunization activities for injectable vaccines using an example of measles and rubella vaccines: field guide. http:\/\/www.who.int\/immunization\/diseases\/measles\/SIA-Field-Guide.pdf: WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2016."},{"key":"10.1016\/j.vaccine.2019.01.081_b0245","series-title":"Response to measles outbreaks in measles mortality reduction settings","author":"World Health Organiazation","year":"2009"},{"issue":"13","key":"10.1016\/j.vaccine.2019.01.081_b0250","doi-asserted-by":"crossref","DOI":"10.3201\/eid2313.170594","article-title":"Use of a diagonal approach to health system strengthening and measles elimination after a large nationwide outbreak in Mongolia","volume":"23","author":"Hagan","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"140","key":"10.1016\/j.vaccine.2019.01.081_b0255","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0575","article-title":"Measles outbreak response decision-making under uncertainty: a retrospective analysis","volume":"15","author":"Fonnesbeck","year":"2018","journal-title":"J Roy Soc Interface"},{"key":"10.1016\/j.vaccine.2019.01.081_b0260","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwy082","article-title":"Impact of public health responses during a measles outbreak in an Amish community in Ohio: modelling the dynamics of transmission","author":"Gasta\u00f1aduy","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.081_b0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40268-016-0144-x","article-title":"Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development","volume":"16","author":"Adhikari","year":"2016","journal-title":"Drugs R&D"},{"issue":"1623","key":"10.1016\/j.vaccine.2019.01.081_b0270","doi-asserted-by":"crossref","first-page":"20120148","DOI":"10.1098\/rstb.2012.0148","article-title":"Vaccine refusal and the endgame: walking the last mile first","volume":"368","author":"Saint-Victor","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2019.01.081_b0275","doi-asserted-by":"crossref","first-page":"c7452","DOI":"10.1136\/bmj.c7452","article-title":"Wakefield's article linking MMR vaccine and autism was fraudulent","volume":"342","author":"Godlee","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.081_b0280","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/erv.10.36","article-title":"Current controversies in the USA regarding vaccine safety","volume":"9","author":"Chatterjee","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.01.081_b0285","unstructured":"On the ups and downs of measles. Surveillance Report. Stockholm, Sweeden: European Centers for Disease Control; 2012 21 February, 2012."},{"key":"10.1016\/j.vaccine.2019.01.081_b0290","unstructured":"UNICEF. Communications for Development 2016 [updated February 16, 2016; cited February 16, 2016. Available from: https:\/\/www.unicef.org\/cbsc\/index_42150.html."},{"issue":"27","key":"10.1016\/j.vaccine.2019.01.081_b0295","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.vaccine.2009.03.048","article-title":"Use of standardized patients to examine physicians' communication strategies when addressing vaccine refusal: a pilot study","volume":"27","author":"Bryant","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2019.01.081_b0300","first-page":"23","article-title":"SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature","volume":"27","author":"Manakongtreecheep","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"46","key":"10.1016\/j.vaccine.2019.01.081_b0305","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.vaccine.2015.09.075","article-title":"MMR vaccination status of children exempted from school-entry immunization mandates","volume":"33","author":"Buttenheim","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.081_b0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamapediatrics.2015.0291","article-title":"Measles, mandates, and making vaccination the default option","volume":"169","author":"Opel","year":"2015","journal-title":"JAMA Pediatrics"},{"issue":"15","key":"10.1016\/j.vaccine.2019.01.081_b0315","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMp1300765","article-title":"Go big and go fast\u2013vaccine refusal and disease eradication","volume":"368","author":"Omer","year":"2013","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.081_b0320","first-page":"010507","article-title":"Approaches, tools and methods used for setting priorities in health research in the 21(st) century","volume":"6","author":"Yoshida","year":"2016","journal-title":"J Global Health"},{"issue":"10014","key":"10.1016\/j.vaccine.2019.01.081_b0325","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(15)01353-7","article-title":"Systematic reviews and research waste","volume":"387","author":"Chalmers","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.01.081_b0330","unstructured":"Global Polio Eradication Initiative. Polio Research Committee. Accessed May 23, 2017 at http:\/\/polioeradication.org\/tools-and-library\/research-innovation\/polio-research-committee\/; 2008."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.081_b0335","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global polio eradication initiative: lessons learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.081_b0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14760584.2017.1393337","article-title":"Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach","volume":"16","author":"Goodson","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:30Z","timestamp":1759401270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":68,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19301677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerating measles and rubella elimination through research and innovation \u2013 Findings from the Measles & Rubella Initiative research prioritization process, 2016","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}